Kimia Biosciences Ltd.
BSE: KIMIABL.BO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Bombay Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Sameer Goel
- Employees
- 250
- Headquarters
- New Delhi, India
- IPO year
- 2024
- Market cap
- ₹1.8B
- Website
- http://www.kimiabiosciences.com
Loading KIMIABL…
Loading profile data…Frequently asked questions about KIMIABL
What does Kimia Biosciences Ltd. (KIMIABL.BO) do?
Kimia Biosciences Ltd. engages in the manufacture and distribution of pharmaceutical products. It offers bulk drug intermediates and active pharmaceutical ingredients. The company was founded on September 27, 1993 and is headquartered in New Delhi, India.
Where does KIMIABL.BO trade?
Kimia Biosciences Ltd. (KIMIABL.BO) trades on the Bombay Stock Exchange.
What sector is KIMIABL.BO in?
Kimia Biosciences Ltd. (KIMIABL.BO) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Kimia Biosciences Ltd.?
Sameer Goel is the chief executive officer of Kimia Biosciences Ltd. (KIMIABL.BO).
Where is Kimia Biosciences Ltd. headquartered?
Kimia Biosciences Ltd. is headquartered in India.
Does KIMIABL.BO pay a dividend?
Kimia Biosciences Ltd. (KIMIABL.BO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did KIMIABL.BO go public?
Kimia Biosciences Ltd. (KIMIABL.BO) completed its initial public offering in 2024.